Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.043 SGD | +2.38% | -.--% | -4.44% |
03-12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
03-12 | IX Biopharma Introduces New Sublingual Wafer | MT |
Quotes 5-day view
Delayed Quote Singapore S.E.22/04/2024 | 25/04/2024 | 26/04/2024 | 29/04/2024 | |
---|---|---|---|---|
Last | 0.043 $ | 0.041 $ | 0.042 $ | 0.043 $ |
Volume | 196 900 | 179 900 | 20 000 | 20 000 |
Change | +∞% | -4.65% | +2.44% | +2.38% |
Opening | 0.04 | 0.03 | 0.04 | 0.04 |
High | 0.04 | 0.04 | 0.04 | 0.04 |
Low | 0.04 | 0.03 | 0.04 | 0.04 |
Performance
1 day | +2.38% | ||
Current month | -17.31% | ||
1 month | -17.31% | ||
6 months | +7.50% | ||
Current year | -4.44% | ||
1 year | -48.19% | ||
3 years | -82.80% | ||
5 years | -81.70% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.38% | -.--% | -4.44% | -48.19% | 24.23M | ||
-0.56% | +6.08% | +33.25% | +91.41% | 704B | ||
-0.54% | +0.72% | +28.59% | +58.77% | 577B | ||
+4.56% | +1.78% | -3.55% | -7.59% | 348B | ||
-0.31% | +1.43% | +18.16% | +10.73% | 327B | ||
-0.57% | -3.62% | +4.36% | +5.21% | 288B | ||
+0.90% | +8.00% | +14.81% | +3.36% | 234B | ||
+0.20% | +1.93% | +4.93% | -2.28% | 198B | ||
-0.27% | -2.30% | -9.78% | -21.31% | 194B | ||
+1.26% | +1.61% | -3.69% | +16.12% | 147B | ||
+6.09% | +3.46% | -5.59% | -30.68% | 145B | ||
+1.35% | +5.57% | +3.70% | -6.92% | 124B | ||
+0.61% | -9.52% | -13.84% | -35.37% | 89.07B | ||
+1.91% | +3.27% | +17.57% | +17.17% | 85.62B | ||
+0.48% | -2.34% | -19.13% | -19.54% | 81.3B | ||
-0.54% | +14.41% | +37.78% | +15.85% | 65.32B | ||
Average | +0.52% | +0.58% | +6.45% | +2.92% | ||
Weighted average by Cap. | +0.18% | +0.95% | +13.49% | +25.39% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -4.44% | ||
2023 | -65.12% | ||
2022 | -34.18% | ||
2021 | -23.14% | ||
2020 | +13.33% | ||
2019 | +26.40% | ||
2018 | -15.24% | ||
2017 | -25.00% | ||
2016 | -37.08% | ||
2015 | -20.54% |
- Stock Market
- Equities
- 42C Stock
- Quotes iX Biopharma Ltd.